Global Pharma Continuous Granulation Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Summary

According to APO Research, The global Pharma Continuous Granulation market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Pharma Continuous Granulation is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Pharma Continuous Granulation is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Pharma Continuous Granulation is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Pharma Continuous Granulation is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Pharma Continuous Granulation include LB Bohle, GEA, LCI, Chansemt, Thermo Fisher Scientific, Syntegon, Senieer, LÖDIGE and Glatt, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

In terms of production side, this report researches the Pharma Continuous Granulation production, growth rate, market share by manufacturers and by region (region level and country level), from 2020 to 2025, and forecast to 2031.

In terms of consumption side, this report focuses on the sales of Pharma Continuous Granulation by region (region level and country level), by company, by type and by application. from 2020 to 2025 and forecast to 2031.

This report presents an overview of global market for Pharma Continuous Granulation, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Pharma Continuous Granulation, also provides the consumption of main regions and countries. Of the upcoming market potential for Pharma Continuous Granulation, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pharma Continuous Granulation sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Pharma Continuous Granulation market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Pharma Continuous Granulation sales, projected growth trends, production technology, application and end-user industry.

Pharma Continuous Granulation Segment by Company

LB Bohle
GEA
LCI
Chansemt
Thermo Fisher Scientific
Syntegon
Senieer
LÖDIGE
Glatt
Gericke
Pharma Continuous Granulation Segment by Type

Dry Method
Wet Method
Pharma Continuous Granulation Segment by Application

Tablets
Capsules
Others
Pharma Continuous Granulation Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharma Continuous Granulation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharma Continuous Granulation and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharma Continuous Granulation.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Pharma Continuous Granulation market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2020-2031).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharma Continuous Granulation industry.
Chapter 3: Detailed analysis of Pharma Continuous Granulation market competition landscape. Including Pharma Continuous Granulation manufacturers' output value, output and average price from 2020 to 2025, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 7: Production/Production Value of Pharma Continuous Granulation by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 8: Consumption of Pharma Continuous Granulation in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Pharma Continuous Granulation Production Value Estimates and Forecasts (2020-2031)
1.2.2 Global Pharma Continuous Granulation Production Capacity Estimates and Forecasts (2020-2031)
1.2.3 Global Pharma Continuous Granulation Production Estimates and Forecasts (2020-2031)
1.2.4 Global Pharma Continuous Granulation Market Average Price (2020-2031)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 Global Pharma Continuous Granulation Market Dynamics
2.1 Pharma Continuous Granulation Industry Trends
2.2 Pharma Continuous Granulation Industry Drivers
2.3 Pharma Continuous Granulation Industry Opportunities and Challenges
2.4 Pharma Continuous Granulation Industry Restraints
3 Pharma Continuous Granulation Market by Manufacturers
3.1 Global Pharma Continuous Granulation Production Value by Manufacturers (2020-2025)
3.2 Global Pharma Continuous Granulation Production by Manufacturers (2020-2025)
3.3 Global Pharma Continuous Granulation Average Price by Manufacturers (2020-2025)
3.4 Global Pharma Continuous Granulation Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Pharma Continuous Granulation Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Pharma Continuous Granulation Manufacturers, Product Type & Application
3.7 Global Pharma Continuous Granulation Manufacturers Established Date
3.8 Market Competitive Analysis
3.8.1 Global Pharma Continuous Granulation Market CR5 and HHI
3.8.2 Global Top 5 and 10 Pharma Continuous Granulation Players Market Share by Production Value in 2024
3.8.3 2024 Pharma Continuous Granulation Tier 1, Tier 2, and Tier 3
4 Pharma Continuous Granulation Market by Type
4.1 Pharma Continuous Granulation Type Introduction
4.1.1 Dry Method
4.1.2 Wet Method
4.2 Global Pharma Continuous Granulation Production by Type
4.2.1 Global Pharma Continuous Granulation Production by Type (2020 VS 2024 VS 2031)
4.2.2 Global Pharma Continuous Granulation Production by Type (2020-2031)
4.2.3 Global Pharma Continuous Granulation Production Market Share by Type (2020-2031)
4.3 Global Pharma Continuous Granulation Production Value by Type
4.3.1 Global Pharma Continuous Granulation Production Value by Type (2020 VS 2024 VS 2031)
4.3.2 Global Pharma Continuous Granulation Production Value by Type (2020-2031)
4.3.3 Global Pharma Continuous Granulation Production Value Market Share by Type (2020-2031)
5 Pharma Continuous Granulation Market by Application
5.1 Pharma Continuous Granulation Application Introduction
5.1.1 Tablets
5.1.2 Capsules
5.1.3 Others
5.2 Global Pharma Continuous Granulation Production by Application
5.2.1 Global Pharma Continuous Granulation Production by Application (2020 VS 2024 VS 2031)
5.2.2 Global Pharma Continuous Granulation Production by Application (2020-2031)
5.2.3 Global Pharma Continuous Granulation Production Market Share by Application (2020-2031)
5.3 Global Pharma Continuous Granulation Production Value by Application
5.3.1 Global Pharma Continuous Granulation Production Value by Application (2020 VS 2024 VS 2031)
5.3.2 Global Pharma Continuous Granulation Production Value by Application (2020-2031)
5.3.3 Global Pharma Continuous Granulation Production Value Market Share by Application (2020-2031)
6 Company Profiles
6.1 LB Bohle
6.1.1 LB Bohle Comapny Information
6.1.2 LB Bohle Business Overview
6.1.3 LB Bohle Pharma Continuous Granulation Production, Value and Gross Margin (2020-2025)
6.1.4 LB Bohle Pharma Continuous Granulation Product Portfolio
6.1.5 LB Bohle Recent Developments
6.2 GEA
6.2.1 GEA Comapny Information
6.2.2 GEA Business Overview
6.2.3 GEA Pharma Continuous Granulation Production, Value and Gross Margin (2020-2025)
6.2.4 GEA Pharma Continuous Granulation Product Portfolio
6.2.5 GEA Recent Developments
6.3 LCI
6.3.1 LCI Comapny Information
6.3.2 LCI Business Overview
6.3.3 LCI Pharma Continuous Granulation Production, Value and Gross Margin (2020-2025)
6.3.4 LCI Pharma Continuous Granulation Product Portfolio
6.3.5 LCI Recent Developments
6.4 Chansemt
6.4.1 Chansemt Comapny Information
6.4.2 Chansemt Business Overview
6.4.3 Chansemt Pharma Continuous Granulation Production, Value and Gross Margin (2020-2025)
6.4.4 Chansemt Pharma Continuous Granulation Product Portfolio
6.4.5 Chansemt Recent Developments
6.5 Thermo Fisher Scientific
6.5.1 Thermo Fisher Scientific Comapny Information
6.5.2 Thermo Fisher Scientific Business Overview
6.5.3 Thermo Fisher Scientific Pharma Continuous Granulation Production, Value and Gross Margin (2020-2025)
6.5.4 Thermo Fisher Scientific Pharma Continuous Granulation Product Portfolio
6.5.5 Thermo Fisher Scientific Recent Developments
6.6 Syntegon
6.6.1 Syntegon Comapny Information
6.6.2 Syntegon Business Overview
6.6.3 Syntegon Pharma Continuous Granulation Production, Value and Gross Margin (2020-2025)
6.6.4 Syntegon Pharma Continuous Granulation Product Portfolio
6.6.5 Syntegon Recent Developments
6.7 Senieer
6.7.1 Senieer Comapny Information
6.7.2 Senieer Business Overview
6.7.3 Senieer Pharma Continuous Granulation Production, Value and Gross Margin (2020-2025)
6.7.4 Senieer Pharma Continuous Granulation Product Portfolio
6.7.5 Senieer Recent Developments
6.8 LÖDIGE
6.8.1 LÖDIGE Comapny Information
6.8.2 LÖDIGE Business Overview
6.8.3 LÖDIGE Pharma Continuous Granulation Production, Value and Gross Margin (2020-2025)
6.8.4 LÖDIGE Pharma Continuous Granulation Product Portfolio
6.8.5 LÖDIGE Recent Developments
6.9 Glatt
6.9.1 Glatt Comapny Information
6.9.2 Glatt Business Overview
6.9.3 Glatt Pharma Continuous Granulation Production, Value and Gross Margin (2020-2025)
6.9.4 Glatt Pharma Continuous Granulation Product Portfolio
6.9.5 Glatt Recent Developments
6.10 Gericke
6.10.1 Gericke Comapny Information
6.10.2 Gericke Business Overview
6.10.3 Gericke Pharma Continuous Granulation Production, Value and Gross Margin (2020-2025)
6.10.4 Gericke Pharma Continuous Granulation Product Portfolio
6.10.5 Gericke Recent Developments
7 Global Pharma Continuous Granulation Production by Region
7.1 Global Pharma Continuous Granulation Production by Region: 2020 VS 2024 VS 2031
7.2 Global Pharma Continuous Granulation Production by Region (2020-2031)
7.2.1 Global Pharma Continuous Granulation Production by Region: 2020-2025
7.2.2 Global Pharma Continuous Granulation Production Forecast by Region: 2026-2031
7.3 Global Pharma Continuous Granulation Production by Region: 2020 VS 2024 VS 2031
7.4 Global Pharma Continuous Granulation Production Value by Region (2020-2031)
7.4.1 Global Pharma Continuous Granulation Production Value by Region: 2020-2025
7.4.2 Global Pharma Continuous Granulation Production Value by Region (2026-2031)
7.5 Global Pharma Continuous Granulation Market Price Analysis by Region (2020-2031)
7.6 Regional Production Value Trends (2020-2031)
7.6.1 North America Pharma Continuous Granulation Production Value (2020-2031)
7.6.2 Europe Pharma Continuous Granulation Production Value (2020-2031)
7.6.3 Asia-Pacific Pharma Continuous Granulation Production Value (2020-2031)
7.6.4 South America Pharma Continuous Granulation Production Value (2020-2031)
7.6.5 Middle East & Africa Pharma Continuous Granulation Production Value (2020-2031)
8 Global Pharma Continuous Granulation Consumption by Region
8.1 Global Pharma Continuous Granulation Consumption by Region: 2020 VS 2024 VS 2031
8.2 Global Pharma Continuous Granulation Consumption by Region (2020-2031)
8.2.1 Global Pharma Continuous Granulation Consumption by Region (2020-2025)
8.2.2 Global Pharma Continuous Granulation Consumption by Region (2026-2031)
8.3 North America
8.3.1 North America Pharma Continuous Granulation Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
8.3.2 North America Pharma Continuous Granulation Consumption by Country (2020-2031)
8.3.3 U.S.
8.3.4 Canada
8.3.5 Mexico
8.4 Europe
8.4.1 Europe Pharma Continuous Granulation Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
8.4.2 Europe Pharma Continuous Granulation Consumption by Country (2020-2031)
8.4.3 Germany
8.4.4 France
8.4.5 U.K.
8.4.6 Italy
8.4.7 Netherlands
8.5 Asia Pacific
8.5.1 Asia Pacific Pharma Continuous Granulation Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
8.5.2 Asia Pacific Pharma Continuous Granulation Consumption by Country (2020-2031)
8.5.3 China
8.5.4 Japan
8.5.5 South Korea
8.5.6 Southeast Asia
8.5.7 India
8.5.8 Australia
8.6 South America
8.6.1 South America Pharma Continuous Granulation Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
8.6.2 South America Pharma Continuous Granulation Consumption by Country (2020-2031)
8.6.3 Brazil
8.6.4 Argentina
8.6.5 Chile
8.6.6 Colombia
8.7 Middle East & Africa
8.7.1 Middle East & Africa Pharma Continuous Granulation Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
8.7.2 Middle East & Africa Pharma Continuous Granulation Consumption by Country (2020-2031)
8.7.3 Egypt
8.7.4 South Africa
8.7.5 Israel
8.7.6 Türkiye
8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
9.1 Pharma Continuous Granulation Value Chain Analysis
9.1.1 Pharma Continuous Granulation Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Pharma Continuous Granulation Production Mode & Process
9.2 Pharma Continuous Granulation Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Pharma Continuous Granulation Distributors
9.2.3 Pharma Continuous Granulation Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings